Indomethacin
27 NDCs across 7 manufacturers|27 Generic,0 Brand
Indomethacin is used to treat gouty arthritis, rheumatoid arthritis, bursitis, patent ductus arteriosus, inflammation and osteoarthritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jun 18, 1985. FDA's Orange Book lists 25 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $5 million on Indomethacin across 266,000 claims for 133,000 beneficiaries.
Indomethacin is available as 27 NDCs from 7 manufacturers (27 generic, 0 brand), with NADAC prices from $0.09 to $0.75 per EA — the most expensive product costs about 8.0× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
27
27G / 0B
Manufacturers
7
competing in market
Price Spread
$0.09 – $0.75
per EA
7d Activity
avg +1.3% WoW · of 27 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Glenmark Pharmaceuticals Inc., USA manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Nonsteroidal Anti-inflammatory Drug class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
7 manufacturers producing INDOMETHACIN
Frequently Asked Questions
What is Indomethacin used to treat?
Indomethacin is used to treat gouty arthritis, rheumatoid arthritis, bursitis, patent ductus arteriosus, inflammation and osteoarthritis, per the National Library of Medicine's MED-RT classification.
When did Indomethacin become available as a generic?
FDA approved the first generic Indomethacin (ANDA) on Jun 18, 1985. The Orange Book currently lists 25 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Indomethacin?
In 2024, Medicare Part D spent $5 million on Indomethacin across 266,000 claims for 133,000 beneficiaries.
How many Indomethacin products are on the market?
The Indomethacin drug market contains 27 NDCs from 7 manufacturers — 27 generic and 0 brand products.
What is the price range for Indomethacin?
NADAC reference prices for Indomethacin range from $0.0934 to $0.7482 per EA — the most expensive product costs about 8.0× the cheapest.
Which manufacturers make Indomethacin?
7 manufacturers list Indomethacin in NADAC. Ranked by number of NDCs, the largest are Glenmark Pharmaceuticals Inc., USA (7), KVK-Tech Inc. (5), Amneal Pharmaceuticals LLC (4), Camber Pharmaceuticals Inc. (4), Chartwell RX LLC (4).
How has the price of Indomethacin changed recently?
Over the past 7 days, 13 Indomethacin NDCs rose and 6 fell, with a market-wide average change of +1.3%.